Related Experiment Video
Updated: Oct 14, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
Ruyi Li1, Xin Song2, Yanan Guo3,4
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
Tumor-associated angiogenesis is a key target for anti-cancer therapy. The imbalance between pro-angiogenic and anti-angiogenic signals elicited by tumor cells or tumor microenvironment always results in activating "angiogenic switch". Tumor angiogenesis functions in multi-aspects of tumor biology, including endothelial cell apoptosis, tumor metastasis, and cancer stem cell proliferation. Numerous studies have indicated the important roles of inexpensive and less toxic natural products in targeting tumor angiogenesis-associated cytokines and apoptotic signaling pathways. Our current knowledge of tumor angiogenesis is based mainly on experiments performed on cells and animals, so we summarized the well-established models for angiogenesis both in vitro and in vivo. In this review, we classified and summarized the anti-angiogenic natural agents (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins) in targeting various tumor types according to their chemical structures at present, and discussed the mechanistic principles of these natural products on regulating angiogenesis-associated cytokines and apoptotic signaling pathways. This review is to help understanding the recent progress of natural product research for drug development on anti-tumor angiogenesis.
Insights
Natural products offer a promising avenue for anti-cancer therapy by targeting tumor angiogenesis. This review details natural agents that inhibit blood vessel formation, aiding drug development for cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Tumor-associated angiogenesis, driven by an imbalance of pro- and anti-angiogenic signals, is crucial for tumor growth, metastasis, and cancer stem cell proliferation.
- Natural products are recognized for their potential in cancer therapy due to their low toxicity and cost-effectiveness.
- Understanding established in vitro and in vivo angiogenesis models is essential for evaluating anti-cancer agents.
Purpose of the Study:
- To review and classify natural products with anti-angiogenic properties.
- To explore the mechanisms by which these natural agents target tumor angiogenesis-associated cytokines and apoptotic pathways.
- To provide insights into natural product research for developing novel anti-tumor angiogenesis drugs.
Main Methods:
- Literature review and classification of natural anti-angiogenic agents based on chemical structures (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins).
- Analysis of mechanistic principles of natural products in regulating angiogenesis-associated cytokines and apoptotic signaling pathways.
- Summary of established in vitro and in vivo models for studying tumor angiogenesis.
Main Results:
- Identification and categorization of various classes of natural products exhibiting anti-angiogenic effects.
- Elucidation of the molecular mechanisms underlying the anti-angiogenic activity of these natural compounds.
- Discussion of the relevance of different angiogenesis models in the context of natural product research.
Conclusions:
- Natural products represent a valuable resource for developing targeted anti-cancer therapies by inhibiting tumor angiogenesis.
- Further research into the mechanisms of action and chemical structures of these agents can accelerate drug discovery.
- This review consolidates current knowledge, facilitating future development of natural product-based anti-angiogenic drugs.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Tumor Immunotherapy
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

